fls.txt



item1.txt
The adoption did not have a significant impact on our financial
those fiscal years, which will be fiscal 2019 for us.
prior financial statements presented.
Based on an evaluation, we do not expect
to change the manner or timing of recognizing revenue.
We have evaluated each
of our revenue streams, product sales and contract research and development.
We are currently evaluating the impact of new disclosure requirements
period.
Net income per diluted share amounts assume exercise of all stock options.
greater than one year are classified as long-term.
The fair value of our marketable
We calculate the share-based compensation expense
The increase in stock-based
The tax years 1999 and 2013 through
required disclosures about fair-value measurements.
an asset or liability.
Generally accepted accounting principles utilize a valuation
We do not have any financial
Forward-looking statements may be identified by the use of
or estimated by us in the forward-looking statements.
The increase
in research and development expense.
The decrease in selling, general, and administrative
taxes for the quarter, compared to 32.3% in the prior-year quarter.
The decrease
increase was due to a 33% increase in contract research and development revenue.


